Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
45
Number of overlapping holdings
59.2%
% of FXH's 77 holdings also in RSPH
76.3%
% of RSPH's 59 holdings also in FXH
Overlap by Weight
Sector Drift (FXH minus RSPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FXH |
Weight in RSPH |
Overlap | |
|---|---|---|---|---|
 |
UNIVERSAL HEALTH SERVICES-B | 2.3% | 1.8% | 1.8% |
|
ZIMMER HOLDINGS INC | 1.9% | 1.8% | 1.8% |
|
CARDINAL HEALTH INC | 2.6% | 1.8% | 1.8% |
|
DAVITA INC | 1.8% | 1.7% | 1.7% |
|
ELEVANCE HEALTH INC | 2.1% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
FXH Overweight Relative to RSPH
|
INTRA-CELLULAR THERAPIES INC | 2.8% |
|
REPROS THERAPEUTICS INC | 2.8% |
|
EXELIXIS INC | 2.5% |
|
DOXIMITY, INC. CLASS A | 2.5% |
|
TENET HEALTHCARE CORP | 2.4% |
 |
JAZZ PHARMACEUTICALS PLC | 2.2% |
|
NATERA INC | 2.0% |
|
PREMIER INC-CLASS A | 2.0% |
|
PENUMBRA, INC. | 2.0% |
 |
ROIVANT SCIENCES LTD. | 2.0% |
FXH Underweight Relative to RSPH
|
CENCORA INC | -1.8% |
|
MCKESSON CORP | -1.7% |
|
CVS CAREMARK CORP | -1.7% |
|
BOSTON SCIENTIFIC CORP | -1.7% |
|
IDEXX LABORATORIES INC | -1.7% |
|
BRISTOL-MYERS SQUIBB CO | -1.7% |
|
VERTEX PHARMACEUTICALS INC | -1.6% |
|
AMGEN INC | -1.6% |
|
GILEAD SCIENCES INC | -1.6% |
|
BIO-TECHNE CORPORATION | -1.6% |